undamentalytics Newsletter
Sign in

Clarivate PLC (CLVT) stock

Add to watchlist

Add holding +

NYSE: CLVT NYSE Research & Consulting Services Next results ~November 3, 2026

Clarivate PLC is a US-listed company in the research & consulting services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Clarivate PLC valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 2 selling4 purchases and 4 sales by directors and officers, last 12 monthsInsider trades
  • Funds123 adding, 140 cuttingOf 35 active managers that changed their stake, 16 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Clarivate files

10-Q filed November 3: Clarivate PLC

Clarivate's revenue reached $2.56bn in the twelve months to September 2026, a 6.4% rise on the prior year and an acceleration from the 4.5% growth recorded a quarter earlier. Profitability moved the other way, with the free-cash-flow margin slipping to 12.6% from 13.9% a year before. Meanwhile, the diluted share count has shrunk by 6.2% over the same period, which boosts the claim each remaining share has on the business. Taken together, these shifts leave our cash-flow model value at $0.87 a share, well below the current price of $1.66.

Our model value for Clarivate is under review, so past values are not shown until it is resolved.

Source: 10-Q filed November 3, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Clarivate PLC stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $2.41bn, down 3.5% on a year earlier, about the same pace as a quarter earlier. Free-cash-flow margin held at 13.6%. The diluted share count is down 6.8% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 0 of our 6 financial-health checks.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 3, 2026 (estimated)

Clarivate PLC's trailing-twelve-month revenue grew 6.4% year on year, with a free-cash-flow margin of 12.6%.

Our discounted-cash-flow model values the business at ~$0.9 per share in the base case (—–$3.3 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Operating margin compressing: TTM operating margin fell to -2.9%, down 1.6pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 6.2% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 5.0% over 90 days.

Things to watch

  • Loss-making. Operating margin is -2.9%: costs exceed revenue.
  • High debt. Long-term debt exceeds cash by $3.9bn, more than 1.5 times annual revenue.
  • Volatile shares. Over the past year the shares showed annualised volatility of 76% and a beta of 0.7 against the S&P 500.
  • Heavily shorted. 13.3% of the shares available to trade are sold short (11.4 days of average volume to cover).

Latest results: FY2026 Q3

Filed November 3, 2026
Earnings per share
$0.19 against an average estimate of $0.18: beat by 4.9%
Revenue
$482m, down 9.2% on a year earlier
Next report
November 3, 2026; average EPS estimate $0.16

Clarivate's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.6%
  • 1 week-11.2%
  • 1 month+12.2%
  • This year-50.3%
  • 1 year-51.2%
  • 5 years-93.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$2.6B
Operating margin
-2.9%
Net margin
-15.1%
EPS (TTM, diluted)
$-0.60

Growth

Revenue growth
+6.4%
Change in growth rate
+2.0 pts
Share count change
−6.2%

Cash

Free cash flow (TTM)
$322M
FCF margin
12.6%
Stock pay % of revenue
2.1%

Earnings

Last results
November 3, 2026
Next results (est.)
February 23, 2027

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Announcement
  4. Announcement
  5. Announcement
  6. Insider trade
  7. Insider trade
  8. Leadership
  9. Results
  10. Leadership
  11. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Clarivate PLC valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Clarivate PLC as an operating company, with every model that fits that kind of business. Cost of equity 9.3%: the 10-year Treasury yield (4.9%) plus a beta of 0.96 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$12 ~$11–$15 Left out: out of range vs price (6.90x)
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Clarivate PLC with Research & Consulting Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20182019202020212022202320242025Now
Share price$9.55$16.80$29.71$23.52$8.34$9.26$5.08$3.34$1.66
Market value$16m$4.6bn$12.7bn$15.1bn$5.7bn$6.2bn$3.5bn$2.2bn$1.1bn
+ Net debt (− = net cash)$2.0bn$1.6bn$3.3bn$5.1bn$4.7bn$4.4bn$4.3bn$4.1bn$3.9bn
Enterprise value$2.0bn$6.2bn$16.0bn$20.2bn$10.4bn$10.6bn$7.8bn$6.4bn$5.0bn
Multiples
Price / sales 0.0x4.7x10.1x8.0x2.1x2.4x1.4x0.9x0.4x
Price / earnings —————————
Price / free cash flow —96.4x81.4x73.4x18.5x12.4x9.9x6.2x3.3x
EV / EBITDA 15.4x52.4x59.9x44.8x——17.3x7.7x7.0x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

49 /100

Moderate moat

How hard Clarivate's competitive advantage looks for rivals to wear away, judged from 8 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 9 / 20

    Cash operating profit has been a median 7.5% of total assets over 6 years.

  • Pricing power 20 / 20

    Gross margin has been a median 65.9%, moving by 0.9 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -5.7%; its worst year was -165.5%.

  • Cash conversion 17 / 20

    Free cash flow was positive in 7 of 7 years, at a median 13.9% of revenue.

  • Discipline 8 / 20

    The diluted share count rose 85.0% over five years; stock-based pay has been a median 3.3% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (64 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 3, 2026, before the open. Analysts expect revenue of $490m and EPS of $0.16 (range $0.16 to $0.16) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.72 +4% $2.2bn −10%
Next $0.78 +8% $2.0bn −9%

Next year's EPS estimate has moved +5.0% in 90 days, across 3 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −1.5% on 90 days ago. In the last 30 days, 2 analysts raised Clarivate PLC's forecast and 1 cut it.

Consensus EPS forecast Clarivate PLC, last 90 days
$0.70 $0.72 $0.74 $0.76 $0.78 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $0.73 Current fiscal year, 60 days ago: $0.71 Current fiscal year, 30 days ago: $0.71 Current fiscal year, 7 days ago: $0.71 Current fiscal year, Now: $0.72 $0.72 Next fiscal year, 90 days ago: $0.74 Next fiscal year, 60 days ago: $0.72 Next fiscal year, 30 days ago: $0.72 Next fiscal year, 7 days ago: $0.72 Next fiscal year, Now: $0.78 $0.78

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $0.73$0.74
60 days ago $0.71$0.72
30 days ago $0.71$0.72
7 days ago $0.71$0.72
Now $0.72$0.78

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.18 $0.19 +4.9%
Mar 2026 $0.14 $0.18 +24.8%
Dec 2025 $0.16 $0.20 +22.2%
Sept 2025 $0.16 $0.18 +15.1%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

9 analysts, Oct 2026
Buy222%
Hold667%
Sell111%

Monthly trend

  1. Oct 20262619
  2. Sep 20262518
  3. Aug 20262518

Counts of recommendations published by analysts covering Clarivate PLC, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
13.3%
of tradable shares
Days to cover
11.36
at average volume
Short interest, 1 month
−3%
to October 15, 2026
Held by institutions
93%
of shares
Held by insiders
18.3%
of shares
Employees
12,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −51.2%

$3.40 on October 31, 2025 to $1.66

ThenNowEffect
Revenue (last 12 months) $2.5bn $2.6bn +4.5%
P/S multiple 0.9x 0.4x −56.5%
Share count 698m 651m +7.3%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −75.8%

$6.87 on November 3, 2023 to $1.66

ThenNowEffect
Revenue (last 12 months) $2.6bn $2.6bn +0.1%
P/S multiple 1.8x 0.4x −76.8%
Share count 676m 651m +3.9%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CLVT−21%−65%+11%−45%−34%−50%
Industry peers (median)+38%−15%+13%+2%−15%−0%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CLVT50%25%33%33%42%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CLVT−38%−67%−47%−54%−45%−58%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since October 29, 2018: 96% from June 7, 2021 to October 5, 2026. Getting back needed a 2212% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.45 – $3.76
From 52-week high
−55.9%
vs 50-day average
−8.5%
vs 200-day average
−25.2%
Volatility (1 year)
76%
Beta vs S&P 500
0.74

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 7 down
typical move ±16.8%
After a week
4 up, 7 down
typical move ±15.7%
After a month
6 up, 5 down
typical move ±14.1%
Results releasedNext dayS&P 500 next day5 days21 days
July 29, 2026 −16.3% +0.1% −19.2% −15.4%
April 29, 2026 +14.3% +1.0% +10.8% +0.8%
February 24, 2026 +36.9% +1.6% +47.0% +47.6%
October 29, 2025 −11.0% −1.1% −4.4% +3.3%
July 30, 2025 −9.0% −0.5% −10.6% +1.9%
April 29, 2025 +20.1% +0.7% +16.2% +18.4%
February 19, 2025 +0.2% −0.2% −5.8% −11.4%
November 6, 2024 −29.0% +3.3% −27.9% −13.2%
August 6, 2024 −17.4% +0.2% +0.8% +8.3%
May 8, 2024 −10.2% +0.6% −8.1% −18.1%
February 27, 2024 −20.9% +0.1% −21.6% −16.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Clarivate PLC
$2.4B $2.5B $2.6B $2.7B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $2.6B Revenue (TTM), FY24 Q1: $2.6B Revenue (TTM), FY24 Q2: $2.6B Revenue (TTM), FY24 Q3: $2.6B Revenue (TTM), FY24 Q4: $2.6B Revenue (TTM), FY25 Q1: $2.5B Revenue (TTM), FY25 Q2: $2.5B Revenue (TTM), FY25 Q3: $2.4B Revenue (TTM), FY25 Q4: $2.7B Revenue (TTM), FY26 Q1: $2.6B Revenue (TTM), FY26 Q2: $2.6B Revenue (TTM), FY26 Q3: $2.6B $2.6B

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $2.6B
FY24 Q1 $2.6B
FY24 Q2 $2.6B
FY24 Q3 $2.6B
FY24 Q4 $2.6B
FY25 Q1 $2.5B
FY25 Q2 $2.5B
FY25 Q3 $2.4B
FY25 Q4 $2.7B
FY26 Q1 $2.6B
FY26 Q2 $2.6B
FY26 Q3 $2.6B
Revenue growth, TTM YoY Clarivate PLC
-10% -5% 0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -1.2% Revenue growth, TTM YoY, FY24 Q1: -0.2% Revenue growth, TTM YoY, FY24 Q2: -0.2% Revenue growth, TTM YoY, FY24 Q3: -1.6% Revenue growth, TTM YoY, FY24 Q4: -2.7% Revenue growth, TTM YoY, FY25 Q1: -3.5% Revenue growth, TTM YoY, FY25 Q2: -3.9% Revenue growth, TTM YoY, FY25 Q3: -6.6% Revenue growth, TTM YoY, FY25 Q4: 3.8% Revenue growth, TTM YoY, FY26 Q1: 4.6% Revenue growth, TTM YoY, FY26 Q2: 4.5% Revenue growth, TTM YoY, FY26 Q3: 6.4% 6.4%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -1.2%
FY24 Q1 -0.2%
FY24 Q2 -0.2%
FY24 Q3 -1.6%
FY24 Q4 -2.7%
FY25 Q1 -3.5%
FY25 Q2 -3.9%
FY25 Q3 -6.6%
FY25 Q4 3.8%
FY26 Q1 4.6%
FY26 Q2 4.5%
FY26 Q3 6.4%
Operating margin (TTM) Clarivate PLC
-40% -20% 0% 20% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: -27.9% Operating margin (TTM), FY24 Q1: -29.9% Operating margin (TTM), FY24 Q2: -36.0% Operating margin (TTM), FY24 Q3: -38.9% Operating margin (TTM), FY24 Q4: -10.8% Operating margin (TTM), FY25 Q1: -11.9% Operating margin (TTM), FY25 Q2: -2.2% Operating margin (TTM), FY25 Q3: -1.3% Operating margin (TTM), FY25 Q4: 3.3% Operating margin (TTM), FY26 Q1: 5.3% Operating margin (TTM), FY26 Q2: -2.6% Operating margin (TTM), FY26 Q3: -2.9% -2.9%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 -27.9%
FY24 Q1 -29.9%
FY24 Q2 -36.0%
FY24 Q3 -38.9%
FY24 Q4 -10.8%
FY25 Q1 -11.9%
FY25 Q2 -2.2%
FY25 Q3 -1.3%
FY25 Q4 3.3%
FY26 Q1 5.3%
FY26 Q2 -2.6%
FY26 Q3 -2.9%
FCF margin (TTM) Clarivate PLC
12% 14% 16% 18% 20% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 19.1% FCF margin (TTM), FY24 Q1: 17.0% FCF margin (TTM), FY24 Q2: 15.4% FCF margin (TTM), FY24 Q3: 16.5% FCF margin (TTM), FY24 Q4: 14.0% FCF margin (TTM), FY25 Q1: 14.1% FCF margin (TTM), FY25 Q2: 13.8% FCF margin (TTM), FY25 Q3: 13.9% FCF margin (TTM), FY25 Q4: 13.8% FCF margin (TTM), FY26 Q1: 12.6% FCF margin (TTM), FY26 Q2: 12.5% FCF margin (TTM), FY26 Q3: 12.6% 12.6%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 19.1%
FY24 Q1 17.0%
FY24 Q2 15.4%
FY24 Q3 16.5%
FY24 Q4 14.0%
FY25 Q1 14.1%
FY25 Q2 13.8%
FY25 Q3 13.9%
FY25 Q4 13.8%
FY26 Q1 12.6%
FY26 Q2 12.5%
FY26 Q3 12.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 918 968 974 1,254 1,877 2,660 2,629 2,557 2,455 2,563
Gross profit — — 622 815 1,251 1,706 1,722 1,688 1,622 1,724
EBITDA 81 132 118 267 451 −3,215 −26 451 829 717
Operating income −147 −106 −82 −36 −87 −3,926 −735 −276 72 −74
Net income −264 −242 −259 −351 −271 −3,960 −911 −637 −201 −387
Diluted EPS −$160.83 −$1.11 −$0.94 −$0.82 −$0.61 −$6.24 −$1.47 −$0.96 −$0.30 −$0.60
Growth (year on year)
Revenue — +5.5% +0.6% +28.7% +49.7% +41.7% −1.2% −2.7% −4.0% +6.4%
EBITDA — +61.5% −10.2% +126.1% +68.9% −813.2% — — +83.6% +2.3%
Margins
Gross margin — — 63.9% 65.0% 66.6% 64.1% 65.5% 66.0% 66.0% 67.3%
EBITDA margin 8.9% 13.6% 12.1% 21.3% 24.0% −120.9% −1.0% 17.7% 33.8% 28.0%
Operating margin −16.0% −10.9% −8.5% −2.9% −4.6% −147.6% −27.9% −10.8% 2.9% −2.9%
Net margin −28.8% −25.0% −26.5% −28.0% −14.4% −148.9% −34.7% −24.9% −8.2% −15.1%
Free-cash-flow margin −3.4% −7.4% 4.9% 12.4% 10.9% 11.5% 19.1% 14.0% 14.9% 12.6%
Cash flow
Cash from operations 7 −26 118 264 324 509 744 647 629 559
Capital spending 38 45 70 108 119 203 243 289 263 237
Free cash flow −31 −72 48 156 205 306 502 358 365 322
Stock-based pay 18 14 51 34 33 94 109 60 63 55
Free cash flow after stock pay −49 −85 −4 122 172 213 393 298 302 268
Balance sheet
Cash 53 26 76 258 431 357 371 295 329 257
Total debt 2,061 2,029 1,665 3,547 5,567 5,071 4,770 4,571 4,470 4,176
Net debt (negative = net cash) 2,008 2,003 1,589 3,290 5,136 4,715 4,400 4,276 4,141 3,919
Diluted shares 2m 2m 274m 427m 641m 679m 672m 694m 673m 643m
Returned to shareholders
Dividends — — — 0 19 75 76 38 0 —
Buybacks — — — 0 159 175 100 200 225 93
Total returned — — — 0 178 250 176 238 225 93

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

0 of 6 checks passed · September 30, 2026
What it owns · $10.4bn
Short-term assets $1.2bnLonger-term assets $9.1bn
What it owes, and who funded it · $10.4bn
Short-term liabilities $1.4bnLonger-term liabilities $4.4bnShareholders' equity $4.5bn
  • Short-term assets cover short-term liabilities $1.2bn of assets due within a year against $1.4bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.2bn short-term assets against $4.4bn of longer-dated liabilities.
  • More cash than debt $257m of cash against $4.1bn of debt.
  • Debt below 40% of shareholders' equity Debt is 92% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 47% to 92% over five years.
  • A year's operating cash flow covers at least 20% of debt $559m of operating cash flow against $4.1bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Clarivate PLC's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$93.1M
Dividends (TTM)
$0
Returned to shareholders
61%
of free cash flow
Buybacks, last 3 fiscal years
$525M
Diluted share count
−6.2%
year over year
Total shareholder yield
8.2%
dividends 0.0% + buybacks 8.2% of market value
Sales & admin spending
29.2%
of revenue
Days sales outstanding
106 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in research & consulting services
Last 12 months unless stated CLVT VRSK ULS ICFI HURN FCN Median
Revenue, last 12 months $2.6bn $3.1bn $3.1bn $1.8bn $1.8bn $4.0bn $632m
Revenue growth, last 12 months 6.4% 5.0% 6.6% −7.9% 13.6% 7.8% 5.0%
Revenue growth, 3-year average −0.7% 6.9% — −1.9% 11.8% 6.0% 6.8%
Revenue growth, latest quarter −9.2% 4.4% 5.2% −0.3% 15.4% 5.9% 4.4%
Gross margin 67.3% 70.2% 50.3% 37.2% 28.6% 32.2% 43.9%
Operating margin −2.9% 43.9% 17.9% 7.8% 10.3% 8.8% 6.1%
Operating margin, 3-year average −14.3% 43.2% 16.3% 7.9% 10.3% 9.8% 6.0%
Net margin −15.1% 28.2% 16.1% 4.9% 6.4% 5.9% 3.1%
Cash from operations / revenue 21.8% 47.9% 21.6% 12.1% 9.9% 9.9% 9.6%
Free-cash-flow margin 12.6% 39.4% 13.9% 10.9% 8.9% 8.9% 7.4%
Free-cash-flow margin, 3-year average 14.3% 34.9% 12.1% 8.4% 9.6% 7.2% 8.6%
Stock pay / revenue 2.1% 1.8% 2.0% 1.2% 2.5% 1.1% 2.3%
Change in share count −6.2% −3.6% 0.6% −2.1% −5.2% −14.5% 0.5%

Median of all 33 companies we cover in research & consulting services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Academia Government Group $1.3B 51.6% ▼ 4.6%
Intellectual Property Group $799M 32.6% ▼ 1.5%
Life Sciences and Healthcare Group $390M 15.9% ▼ 6.9%
Products and services
Line of business Revenue Share YoY
Recurring Revenues $2B 83.1% ▼ 0.8%
Subscription Revenues $1.6B 78.7% ▼ 1.3%
Re Occurring Revenues $434M 21.3% ▲ 1.0%
Transactional Revenues $416M 16.9% ▼ 16.9%
Geography
Region Revenue Share YoY
North America $1.3B 53.1% ▼ 5.7%
EMEA $655M 26.7% ▼ 1.9%
Asia Pacific $497M 20.3% ▼ 2.0%

From Clarivate PLC's 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.3B
Institutions reporting
240
Shares held vs prior quarter
▲ 1.7%
Positions opened / closed
45 / 61

Top buyers and sellers, Q2 2026: 123 institutions bought and 140 sold ; the biggest buyer was Blackrock, Inc (+10.1M shares) and the biggest seller HRT Financial LP (−3.5M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Leonard Green & Partners, L.P. $252M 116.7M 20.0% 0.0%
Exor N.V. $145M 67.3M 11.5% 0.0%
Clarkston Capital Partners, LLC $98.8M 45.7M 7.8% ▲ 6.7%
Blackrock, Inc. $67.3M 31.2M 5.3% ▲ 47.9%
Partners Group Holding AG $55.3M 25.6M 4.4% 0.0%
Fil Ltd $54.6M 25.3M 4.3% 0.0%
Dimensional Fund Advisors LP $41.2M 19.1M 3.3% ▼ 5.7%
Edmond De Rothschild Holding S.A. $35M 16.2M 2.8% ▼ 9.0%
Citadel Advisors LLC $31.6M 14.6M 2.5% ▼ 17.3%
American Century Companies Inc $30.8M 14.3M 2.4% ▲ 14.8%
Invenomic Capital Management LP $30.8M 14.3M 2.4% ▲ 7.1%
First Trust Advisors LP $29.2M 13.5M 2.3% ▲ 145.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Clarivate PLC's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $2.8M 4 trades by 1 insider, last 12 months Insider sales History → $6M 4 trades by 2 insiders · 19% under pre-set plans
Net ▼ $3.2M net selling
Insider Date Trade Shares Price Value
Cornick Kenneth L. Director August 7, 2026 Buy 250,000 $1.85 $462,500
Cornick Kenneth L. Director August 6, 2026 Buy 650,000 $1.86 $1.2M
Snyder Andrew Miles Director August 3, 2026 Sell 2,002,242 $1.94 $3.9M
Snyder Andrew Miles Director August 3, 2026 Sell 310,702 $1.94 $602,762
Snyder Andrew Miles Director August 3, 2026 Sell 176,674 $1.94 $342,748
Veinstein Bar President, A&G December 1, 2025 Sell pre-set plan 309,902 $3.74 $1.2M
Cornick Kenneth L. Director November 10, 2025 Buy 100,000 $3.45 $345,000
Cornick Kenneth L. Director November 3, 2025 Buy 225,000 $3.52 $792,000

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

No trades in Clarivate PLC disclosed in the last 12 months; 6 earlier trades on record.

  • Daniel S. Goldman(D-NY 10):Sale (full), $1,001 - $15,000, traded July 12, 2023, filed August 13, 2023
  • Susie Lee(D-NV 3):Sale (full), $1,001 - $15,000, traded November 30, 2022, filed December 29, 2022
  • Susie Lee(D-NV 3):Purchase, $1,001 - $15,000, traded June 21, 2021, filed July 13, 2021

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 23, 2027 estimated from the company's past filing pattern, not announced

  • November 3, 2026
  • July 29, 2026
  • April 29, 2026
  • February 24, 2026
  • October 29, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Clarivate PLC was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Clarivate PLC in brief

What does Clarivate PLC do?
Clarivate PLC is a US-listed company in the research & consulting services industry. Its financial year ends in December.
What is Clarivate PLC's stock ticker?
Clarivate PLC trades under the ticker CLVT on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Clarivate PLC's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Clarivate PLC reported revenue of $2.6B, 6.4% higher than a year earlier, according to its SEC filings.
What is Clarivate PLC's free cash flow?
Clarivate PLC's free-cash-flow margin is 12.6% of revenue over the trailing twelve months.
Who are Clarivate PLC's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Leonard Green & Partners, L.P., Exor N.V. and Clarkston Capital Partners, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Clarivate PLC buying back stock, and does it pay a dividend?
Clarivate PLC spent $93.1M on share repurchases over the trailing twelve months, and its diluted share count fell 6.2% over the year.
What is Clarivate PLC's market cap?
On November 2, 2026, Clarivate PLC's market capitalisation was about $1.1B and net debt of $3.9B. Market figures come from third-party market data and may be delayed.
Does Clarivate PLC pay a dividend?
Clarivate PLC reported no dividend payments in its trailing twelve months of filings.
How much debt does Clarivate PLC have?
Clarivate PLC's debt-to-equity ratio is 91.6%, from its latest balance sheet (46.6% five years earlier). The financial health section below sets out its other solvency checks.
Who are Clarivate PLC's competitors?
In our Research & Consulting Services peer group, the companies closest to Clarivate PLC are Verisk Analytics, Inc., UL Solutions Inc., ICF International, Inc., Huron Consulting Group Inc. and FTI Consulting, Inc. The side-by-side comparison below sets their revenue, margins and growth against Clarivate PLC's.
Are insiders buying or selling Clarivate PLC stock?
Over the last 12 months, Clarivate PLC's directors and officers reported 4 open-market purchases and 4 sales on Form 4. The insider trading page charts every trade.
When is Clarivate PLC's next earnings date?
Around November 3, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Clarivate PLC announces its own schedule.